Antipsychotics - Articles - Page 9

Lithium Favored in Treatment Effectiveness Study

June 1, 2018

Adam Strassberg, MD. Dr. Strassberg has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A new study from Finland shows that lithium may be more effective than other treatments in reducing the risk of psychiatric rehospitalization in patients with bipolar disorder.

Metformin to Control Antipsychotic-Induced Weight Gain in Children

May 1, 2018

Adam Strassberg, MD

Adam Strassberg, MD Psychiatrist in private practice in Palo Alto, CA. Contributing writer to the Carlat Report newsletters. Dr. Strassberg has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Metformin has been used off-label for weight loss in psychiatry for many years, much of it for help with adult weight gain as a side effect of atypical antipsychotics. However, most trials of metformin for weight loss were actually conducted on the child and adolescent population. This article will look at the quality of the data in our pediatric population of 3 studies, and then come up with some recommendations for your practice.

Note From the Editor-in-Chief

March 1, 2018

Daniel Carlat, MD

Daniel Carlat, MD Editor-in-Chief, The Carlat Psychiatry Report

We publish an issue on antipsychotics at least once a year, and it’s always a challenge to decide what to cover. There are dozens of antipsychotics, and most of them are approved for mood disorders as well as psychosis.

Clozapine: A Fresh Look

March 1, 2018

For those reluctant to make clozapine their go-to antipsychotic for certain patients, this article will provide information to help you decide when it’s right to prescribe.

Abilify MyCite: Patient Care Breakthrough or Patent Extender?

March 1, 2018

You’ve probably heard about a new “digital pill” called Abilify MyCite. The product, which was FDA approved in November 2017, is the first drug in the U.S. with a digital ingestion tracking system.

Prescribing and Managing Antipsychotics

March 1, 2018

Thomas Schwartz, MD

Thomas Schwartz, MD.
Professor and Interim Chair of Psychiatry and Behavioral Sciences, Upstate Medical University, Syracuse, NY. Dr. Schwartz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

For those reluctant to make clozapine their go-to antipsychotic for certain patients, this article will provide information to help you decide when it’s right to prescribe.

Estrogen Modulator Raloxifene Not Helpful for Schizophrenic Women

January 1, 2018

Robert T. Rubin, MD

Robert T. Rubin, MD Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Since estrogen can affect neurotransmitter functioning, there has been some interest in using estrogen modulators to treat psychiatric conditions, including schizophrenia. Raloxifene is a selective estrogen receptor modulator (SERM) with some preliminary evidence for effectiveness in women with schizophrenia.

Cannabidiol Could Alleviate Psychotic Symptoms in Schizophrenia

November 1, 2017

Rehan Aziz, MD.

Rehan Aziz, MD. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Research has shown that heavy cannabis use is associated with new-onset psychosis, so a study exploring the drug’s use as a treatment for schizophrenia is surprising, to say the least.

Treatment of First Episode Psychosis in College Students: It Takes a Team

August 1, 2017

Marcia Morris, MD

Marcia Morris, MD Psychiatrist at the University of Florida. Author of The Campus Cure: A Parent’s Guide to Mental Health and Wellness for College Students, Rowman & Littlefield Publishers (forthcoming 2018) Dr. Morris has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Evaluating a first episode of psychosis in college students is challenging—it’s not clear from the outset if the episode will represent a one-time occurrence or the start of a lifelong illness. The differential diagnosis is large and includes depression with psychotic features, bipolar disorder, a primary psychotic disorder like schizophrenia or schizoaffective disorder, drug-induced psychosis, and transient psychotic episodes.

Evaluating Psychosis in Children

August 1, 2017

Claudio Cepeda, MD

Claudio Cepeda, MD Clinical associate professor in the Department of Psychiatry at UT Health, San Antonio, TX Dr. Cepeda has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity. The author of the Concise Guide to the Psychiatric Interview of Children and Adolescents, as well as a clinician who has served both inpatient and outpatient pediatric populations for decades, Dr. Cepeda shares his interviewing tips on how to detect signs of psychosis in children.

If a kid without psychosis says Freddy Krueger’s in the closet and his parents assure him that no one is in there, he will eventually settle down and fall asleep. A psychotic child will not be able to fall asleep and will persist in his belief no matter how much reassurance he receives. Another important clue is if the child has these fears during the day or at school.